do not combine dpp-4 inhibitors with glp-1 receptor agonists guidance Frontiers GLP-1 Receptor Agonists Have better
Description
The clinical data suggesting a possible association come from post-marketing surveillance data that have substantial risk for bias and do not control for important confounding variables
Fiorucci S, Scionti L, Bosso R, et al

Expanding awareness of their benefits could help more people access these treatments

It may also reduce body weight and strengthen cardiovascular health

Cholesterol is essential for hormone synthesis and cell membranes

GIP, glucose-dependent insulinotropic polypeptide
00174-1/asset/4ff9bb50-3a8f-4946-a683-db1579705072/main.assets/gr1.jpg)